eli lilly retatrutide trials retatrutide (LY3437943) / Eli Lilly

A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes

29.66

★★★★☆4.8 (126)

Retatrutide Phase 3 Results: What Eli Lilly's TRIUMPH-4 Trial Means fo – Summit Pep Labs

29.54

★★★★★4.9 (98)

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)

29.51

★★★★★5.0 (157)

Rachel the Dietitian_ Redefining Menopause for Our Generation | Eli Lilly announced promising Phase 3 trial results for retatrutide, a next-generation obesity medication targeting THREE metabolic

24.24

★★★★★4.7 (84)

Eli Lilly's retatrutide is still in clinical trials. But gym bros are already using a version of the weight-loss drug, amid a growing DIY culture in fitness circles. (Credit: Courtesy of Max

21.54

★★★★★4.9 (203)

Eli Lilly retatrutide Phase 3 obesity trial results 2026

28.94

★★★★★5.0 (176)

The Short | Eli Lilly's Phase 3 clinical trial for retatrutide, a GLP-1 drug, met its primary endpoints, showing a 15.3% improvement in outcomes

26.59

★★★★★4.8 (132)